tetranor-PGJM结构式
|
常用名 | tetranor-PGJM | 英文名 | tetranor-PGJM |
---|---|---|---|---|
CAS号 | 1352751-83-7 | 分子量 | 310.342 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 586.6±35.0 °C at 760 mmHg | |
分子式 | C16H22O6 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 322.6±22.4 °C |
英文名 | 8-[(1R,2S)-2-(2-Carboxyethyl)-5-oxo-3-cyclopenten-1-yl]-6-oxoocta noic acid |
---|---|
英文别名 | 更多 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 586.6±35.0 °C at 760 mmHg |
分子式 | C16H22O6 |
分子量 | 310.342 |
闪点 | 322.6±22.4 °C |
精确质量 | 310.141632 |
PSA | 108.74000 |
LogP | -0.12 |
蒸汽压 | 0.0±3.5 mmHg at 25°C |
折射率 | 1.515 |
~46% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; Location in patent: Page/Page column 21 ; |
~% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGJM 1352751-83-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
tetranor-prostaglandin J metabolite |
tetranor-prostaglandin D metabolite |
3-Cyclopentene-1-octanoic acid, 2-(2-carboxyethyl)-ε,5-dioxo-, (1R,2S)- |
8-[(1R,2S)-2-(2-Carboxyethyl)-5-oxo-3-cyclopenten-1-yl]-6-oxooctanoic acid |
tetranor-prostaglandin A metabolite |
tetranor-PGJM |